DAMPening Severe COVID-19 with Dexamethasone

Infect Disord Drug Targets. 2022;22(2):e270821195910. doi: 10.2174/1871526521999210827142839.

Cédric Annweiler^{1

2

3}, Nicolas Papon⁴, Jean-Marc Sabatier⁵, Jean Barré¹

¹ Department of Geriatric Medicine and Memory Clinic, Research Center on Autonomy and Longevity, University Hospital, Angers, France.
² Univ Angers, EA 4638,, LPPL, SFR CONFLUENCES, F-49000 Angers, France.
³ Robarts Research Institute, Department of Medical Biophysics, Schulich School of Medicine and Dentistry, the University of Western Ontario, London, ON, Canada.
⁴ Univ Angers, Univ Brest, GEIHP, SFR ICAT, F-49000 Angers, France.
⁵ Université Aix-Marseille, Institut de Neuro-physiopathologie (INP), UMR 7051, Faculté de Pharmacie, 27 Bd Jean Moulin, 13385 Marseille Cedex, France.

No abstract available

Keywords: ACE inhibitors; Corticosteroids; HMGB1; hydroxychloroquine; statins; vitamin D.

MeSH terms